PMID: 9428155Jan 15, 1998Paper

A self-assembled antibody electrode for HT29 tumour cells

Biotechnology and Applied Biochemistry
J FengZ Q Guo

Abstract

The present paper describes a self-assembled monoclonal-antibody immunosensor for HT29 tumour cells. This immunosensor is composed of two parts. One is a three-electrode system and the other is a layer of anti-(human colonic tumour) monoclonal antibody DF-I, which self-assembled on to the gold electrode. Two kinds of cells, HT29 tumour cells and normal fibroblast cells, were compared using the antibody electrode. The result was the same as that obtained by using immune luminescence. The HT29 cells can be captured specifically by the assembled anti-HT29 monoclonal-antibody electrode and can be measured by an electrochemical method.

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.